254 related articles for article (PubMed ID: 22459918)
1. Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis.
Strowitzki T; Marr J; Gerlinger C; Faustmann T; Seitz C
Int J Gynaecol Obstet; 2012 Jun; 117(3):228-33. PubMed ID: 22459918
[TBL] [Abstract][Full Text] [Related]
2. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial.
Strowitzki T; Marr J; Gerlinger C; Faustmann T; Seitz C
Hum Reprod; 2010 Mar; 25(3):633-41. PubMed ID: 20089522
[TBL] [Abstract][Full Text] [Related]
3. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
[TBL] [Abstract][Full Text] [Related]
4. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive.
Caruso S; Iraci M; Cianci S; Fava V; Casella E; Cianci A
J Endocrinol Invest; 2016 Aug; 39(8):923-31. PubMed ID: 27023105
[TBL] [Abstract][Full Text] [Related]
5. Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment.
Morotti M; Sozzi F; Remorgida V; Venturini PL; Ferrero S
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():188-92. PubMed ID: 25461377
[TBL] [Abstract][Full Text] [Related]
6. Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study. Gestrinone Italian Study Group.
Fertil Steril; 1996 Dec; 66(6):911-9. PubMed ID: 8941054
[TBL] [Abstract][Full Text] [Related]
7. Dienogest: a new therapeutic agent for the treatment of endometriosis.
Harada T; Taniguchi F
Womens Health (Lond); 2010 Jan; 6(1):27-35. PubMed ID: 20001868
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of dienogest vs combined oral contraceptive on pain associated with endometriosis: Randomized clinical trial.
El Taha L; Abu Musa A; Khalifeh D; Khalil A; Abbasi S; Nassif J
Eur J Obstet Gynecol Reprod Biol; 2021 Dec; 267():205-212. PubMed ID: 34826668
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice.
Techatraisak K; Hestiantoro A; Ruey S; Banal-Silao MJ; Kim MR; Seong SJ; Thaufik S; Ahlers C; Shin SY; Lee BS
BMC Womens Health; 2019 May; 19(1):68. PubMed ID: 31096979
[TBL] [Abstract][Full Text] [Related]
10. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial.
Harada T; Momoeda M; Taketani Y; Aso T; Fukunaga M; Hagino H; Terakawa N
Fertil Steril; 2009 Mar; 91(3):675-81. PubMed ID: 18653184
[TBL] [Abstract][Full Text] [Related]
11. Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission.
Leonardo-Pinto JP; Benetti-Pinto CL; Cursino K; Yela DA
Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():108-111. PubMed ID: 28231497
[TBL] [Abstract][Full Text] [Related]
12. Dienogest in the treatment of endometriosis: systematic review.
Andres Mde P; Lopes LA; Baracat EC; Podgaec S
Arch Gynecol Obstet; 2015 Sep; 292(3):523-9. PubMed ID: 25749349
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain.
Crosignani PG; Luciano A; Ray A; Bergqvist A
Hum Reprod; 2006 Jan; 21(1):248-56. PubMed ID: 16176939
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of depot leuprolide in patients with chronic pelvic pain and clinically suspected endometriosis. Pelvic Pain Study Group.
Ling FW
Obstet Gynecol; 1999 Jan; 93(1):51-8. PubMed ID: 9916956
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data.
Lee JH; Song JY; Yi KW; Lee SR; Lee DY; Shin JH; Cho S; Seo SK; Kim SH
Reprod Sci; 2018 Oct; 25(10):1515-1522. PubMed ID: 29848190
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain.
Guzick DS; Huang LS; Broadman BA; Nealon M; Hornstein MD
Fertil Steril; 2011 Apr; 95(5):1568-73. PubMed ID: 21300339
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.
Schlaff WD; Carson SA; Luciano A; Ross D; Bergqvist A
Fertil Steril; 2006 Feb; 85(2):314-25. PubMed ID: 16595206
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea.
Osuga Y; Hayashi K; Kanda S
Fertil Steril; 2020 Mar; 113(3):627-635.e1. PubMed ID: 32192595
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest.
Caruso S; Iraci M; Cianci S; Casella E; Fava V; Cianci A
J Endocrinol Invest; 2015 Nov; 38(11):1211-8. PubMed ID: 26337183
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of endometriosis with dienogest: preliminary report].
Kamiński K; Fiegler P; Marr J; Moore C
Ginekol Pol; 2001 May; 72(5):299-304. PubMed ID: 11526761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]